Draupnir Bio announces equity investments totalling €12 million with MP Healthcare, EIFO, Gilde Healthcare Partners, Inkef Capital and Novo Holdings
05 July 2024
05 July 2024
Total investments received (USD): 46.13M
Round value (USD): 12.92M
Company: Draupnir Bio
Industry: BiotechHealth services
Related deals
iDEL Therapeutics raised €9m in seed funding led by BioMedVC, joined by NRW.Venture, Gründerfonds Ruhr and KHAN Technology Transfer
Investments
02 March 2026
Rivia raised $15m in Series A funding led by Earlybird, joined by investors including Defiant, Speedinvest, Amino Collective and Nina Capital.
Investments
02 March 2026
Lucida Medical raised £8.7M series A led by IW Capital
Investments
02 March 2026
Syndex Bio in a $15.5M seed round led by ARCH Venture Partners
Investments
14 February 2026
Hybrid Greentech to sell a major equity stake for €15m in an investment from Nordic Alpha Partners
Secondary
07 February 2026
Belgium
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal